University of Maryland BaltImore Life Science Discovery (UM-BILD) Accelerator
马里兰大学巴尔的摩生命科学发现 (UM-BILD) 加速器
基本信息
- 批准号:10783358
- 负责人:
- 金额:$ 100万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-25 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdmission activityAfrican AmericanAppointmentAreaAwardBaltimoreBiological ProductsBiological SciencesBiomedical ResearchBiotechnologyBlack raceBusinessesCancer BiologyCapitalCountyDedicationsDevelopmentDiagnosticDoctor of PhilosophyEconomicsEmployeeEnvironmentEquipmentEquityEvaluation ResearchFacultyFemaleFosteringFundingGoalsGrantGrowthHispanicHistorically Black Colleges and UniversitiesImmunologyIncubatorsIndustryInfrastructureInstitutionInvestmentsLaboratoriesLatinoLettersMarylandMedical DeviceMentorsMicrobiologyMinority-Serving InstitutionNeurosciencesPerformancePharmaceutical PreparationsPopulationPositioning AttributePrivatizationProduct ApprovalsProductivityResearchResearch PersonnelResource DevelopmentResourcesSTEM fieldScholars ProgramScientistServicesSmall Business Innovation Research GrantSmall Business Technology Transfer ResearchSystemTechnologyTrainingTraining ProgramsUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesVaccinescohortcollegecommercializationcurriculum developmentfabricationhealth information technologyinnovationlaboratory developmentmedical schoolsprogramsrecruitsatisfactionsmall moleculesuccesstenure trackundergraduate student
项目摘要
PROJECT SUMMARY/ABSTRACT
The goal of the University of Maryland BaltImore Life Science Discovery Accelerator (UM-BILD) is to create a
new NIH Research Evaluation and Commercialization Hub (REACH) program that serves as a development
engine to build the life science economy in West Baltimore and Greater Baltimore and to train one of the most
diverse biomedical and entrepreneurial workforces in the US. Underrepresented minorities (URM) making up
34% of the population, URMs comprise only 15% of PhD graduates and 4% of tenured faculty positions in
medical schools. Diversity amongst venture-backed founders is even less. This is in the face of evidence that
increased workforce diversity increases productivity, financial performance, and employee satisfaction. UM-BILD
will be formed from a partnership with University of Maryland Baltimore (UMB), University Maryland School of
Medicine (UMSOM), University of Maryland Baltimore County (UMBC) (a Minority Serving Institution), University
of Maryland College Park, Morgan State University (a Historically Black College/University (HBCU)), Blackbird
Laboratories ($100MIL life science institute/incubator), and the Maryland Innovation Initiative (MII). All Baltimore
universities and life science innovators will have access to hub expertise, resources, and networking. UM-BILD
will directly address the need for increased biomedical and startup workforce diversity leveraging existing,
successful initiatives at UMSOM and UMBC. UM-BILD will foster life science industry growth of the
demographically diverse (28% African American and 7% Hispanic) Baltimore Region. UM-BILD will embrace
existing partner programmatic efforts to increase biomedical workforce diversity; as well as direct engagement
with HBCU’s and Minority serving institutions. UM-BILD will solicit, identify, and develop early-stage life science
platforms and projects over the entire spectrum of technology types. UM-BILD will have three specific aims: Aim
1: Provide seed investment and development resources for 11 early-stage technology projects teams per year
enhanced by a $5 million non-federal match funds through partner institutions and MII. Technologies will receive
milestone gated investments of up to $200,000 and access to unique biomedical development facilities at UMB
and UMBC to serve as a dedicated incubator. Aim 2: Train a diverse biomedical and innovation workforce from
elite scientists and innovators. We will offer a dedicated entrepreneurial, project management, and business
development curriculum that will build upon on-going biomedical workforce diversification programs at UMB and
UMBC, and the Baltimore region in general, to allow for a unique cohort of newly trained life science
entrepreneurs, many from URM backgrounds. Aim 3: Create new companies ready to apply for federal
SBIR/STTR awards and raise private capital to grow the life science economy in Baltimore. UM-BILD will provide
services in company formation, training in obtaining federal innovation grants; connections to investors seeking
early-stage life science opportunities (see letters of support); and subsidized space in Baltimore Bioparks.
项目概要/摘要
马里兰大学巴尔的摩生命科学发现加速器 (UM-BILD) 的目标是创建一个
新的 NIH 研究评估和商业化中心 (REACH) 计划作为一项开发
建立西巴尔的摩和大巴尔的摩生命科学经济的引擎,并培养最优秀的人才之一
美国的多元化生物医学和创业劳动力构成了代表性不足的少数群体 (URM)。
34% 的人口,URM 仅包括 15% 的博士毕业生和 4% 的终身教职人员
有证据表明,医学院的创始人的多样性甚至更少。
劳动力多元化的增加可以提高生产力、财务绩效和员工满意度。
将与马里兰大学巴尔的摩分校 (UMB)、马里兰大学学院合作成立
医学(UMSOM),马里兰大学巴尔的摩县(UMBC)(少数族裔服务机构),大学
马里兰大学公园分校、摩根州立大学(一所历史悠久的黑人学院/大学 (HBCU))、黑鸟
实验室(价值 1 亿美元的生命科学研究所/孵化器)和马里兰州创新计划 (MII)。
大学和生命科学创新者将能够获得中心的专业知识、资源和网络。
将直接满足利用现有的、增加生物医学和初创企业劳动力多样性的需求
UMSOM 和 UMBC 的成功举措将促进生命科学行业的发展。
人口多元化(28% 为非裔美国人,7% 为西班牙裔)的巴尔的摩地区将受到 UM-BILD 的欢迎。
现有合作伙伴旨在增加生物医学劳动力多样性以及直接参与的计划努力;
与 HBCU 和少数族裔服务机构合作,UM-BILD 将征集、识别和开发早期生命科学。
涵盖整个技术类型的平台和项目将具有三个具体目标:
1:每年为11个早期技术项目团队提供种子投资和开发资源
通过合作机构和 MII Technologies 将获得 500 万美元的非联邦配套资金。
高达 200,000 美元的里程碑门控投资,并可使用 UMB 独特的生物医学开发设施
和 UMBC 充当专门的孵化器 目标 2:培养多元化的生物医学和创新劳动力。
我们将为精英科学家和创新者提供专门的创业、项目管理和商业服务。
开发课程将建立在UMB正在进行的生物医学劳动力多元化计划的基础上
UMBC 以及整个巴尔的摩地区,为新接受生命科学培训的独特群体提供支持
目标 3:创建准备申请联邦的新公司。
SBIR/STTR 奖励并筹集私人资本,以发展巴尔的摩的生命科学经济。
公司组建服务、获得联邦创新补助金的培训;
早期生命科学机会(参见支持信);以及巴尔的摩生物园的补贴空间。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jason J Rose其他文献
Jason J Rose的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jason J Rose', 18)}}的其他基金
Hemoglobin-based antidotes for the treatment of carbon monoxide poisoning
用于治疗一氧化碳中毒的血红蛋白解毒剂
- 批准号:
10296690 - 财政年份:2020
- 资助金额:
$ 100万 - 项目类别:
Hemoglobin-based antidotes for the treatment of carbon monoxide poisoning
用于治疗一氧化碳中毒的血红蛋白解毒剂
- 批准号:
10282997 - 财政年份:2020
- 资助金额:
$ 100万 - 项目类别:
Hemoglobin-based antidotes for the treatment of carbon monoxide poisoning
用于治疗一氧化碳中毒的血红蛋白解毒剂
- 批准号:
9908358 - 财政年份:2020
- 资助金额:
$ 100万 - 项目类别:
Discovering and Developing Recombinant Molecular Scavenging Agents for the Treatment of Carbon Monoxide Induced Cardiovascular Dysfunction
发现和开发用于治疗一氧化碳引起的心血管功能障碍的重组分子清除剂
- 批准号:
9973110 - 财政年份:2018
- 资助金额:
$ 100万 - 项目类别:
Discovering and Developing Recombinant Molecular Scavenging Agents for the Treatment of Carbon Monoxide Induced Cardiovascular Dysfunction
发现和开发用于治疗一氧化碳引起的心血管功能障碍的重组分子清除剂
- 批准号:
10213117 - 财政年份:2018
- 资助金额:
$ 100万 - 项目类别:
Discovering and Developing Recombinant Molecular Scavenging Agents for the Treatment of Carbon Monoxide Induced Cardiovascular Dysfunction
发现和开发用于治疗一氧化碳引起的心血管功能障碍的重组分子清除剂
- 批准号:
10442531 - 财政年份:2018
- 资助金额:
$ 100万 - 项目类别:
Developing a Low-Cost Intelligent Ventilator with Remote Control for Rapid, Global Deployment and Minimal Healthcare Provider Exposure
开发具有远程控制功能的低成本智能呼吸机,以实现快速全球部署并最大限度地减少医疗保健提供者的暴露
- 批准号:
10166226 - 财政年份:2018
- 资助金额:
$ 100万 - 项目类别:
Carbon Monoxide Inhibition of Mitochondrial Function and Efficacy of a Novel Antidotal Therapeutic for Carbon Monoxide Poisoning
一氧化碳对线粒体功能的抑制以及新型一氧化碳中毒解毒疗法的功效
- 批准号:
9121057 - 财政年份:2016
- 资助金额:
$ 100万 - 项目类别:
相似海外基金
Developing Real-world Understanding of Medical Music therapy using the Electronic Health Record (DRUMMER)
使用电子健康记录 (DRUMMER) 培养对医学音乐治疗的真实理解
- 批准号:
10748859 - 财政年份:2024
- 资助金额:
$ 100万 - 项目类别:
Investigators from Novices, a Transdisciplinary Research Education Program to Increase Diversity (INTREPID) in Aging Research
新手研究人员,一项旨在增加衰老研究多样性的跨学科研究教育计划 (INTREPID)
- 批准号:
10625709 - 财政年份:2023
- 资助金额:
$ 100万 - 项目类别:
University of Louisville Biomedical Integrative Opportunity for Mentored Experience Development -PREP (UL-BIOMED-PREP)
路易斯维尔大学生物医学综合指导经验开发机会 -PREP (UL-BIOMED-PREP)
- 批准号:
10557638 - 财政年份:2023
- 资助金额:
$ 100万 - 项目类别:
Enhancing Mentoring of Diverse Early Career Researchers
加强对多元化早期职业研究人员的指导
- 批准号:
10797836 - 财政年份:2023
- 资助金额:
$ 100万 - 项目类别: